1. Home
  2. CDE vs ALGN Comparison

CDE vs ALGN Comparison

Compare CDE & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeur Mining Inc.

CDE

Coeur Mining Inc.

HOLD

Current Price

$17.68

Market Cap

13.5B

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$178.58

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDE
ALGN
Founded
1928
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Industrial Specialties
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
12.7B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
CDE
ALGN
Price
$17.68
$178.58
Analyst Decision
Strong Buy
Buy
Analyst Count
5
12
Target Price
$22.40
$199.82
AVG Volume (30 Days)
15.8M
956.9K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
533.33
0.53
EPS
0.95
5.65
Revenue
$709,598,000.00
$387,126,000.00
Revenue This Year
$165.39
$5.78
Revenue Next Year
$12.10
$4.62
P/E Ratio
$18.81
$30.94
Revenue Growth
N/A
23.95
52 Week Low
$5.27
$122.00
52 Week High
$27.77
$208.31

Technical Indicators

Market Signals
Indicator
CDE
ALGN
Relative Strength Index (RSI) 41.38 46.95
Support Level $16.94 $175.35
Resistance Level $17.88 $183.34
Average True Range (ATR) 0.82 6.23
MACD -0.14 -1.41
Stochastic Oscillator 14.01 33.42

Price Performance

Historical Comparison
CDE
ALGN

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico generating maximum revenue from United States.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: